Rapid testing of C. diff patients

Triggered by antibiotic use, Clostridium difficile is the main cause of hospitalacquired diarrhoea. INVERNESS MEDICAL has introduced two new rapid tests.

TechLab TOX A/B Quik Chek and BioStar OIA CdTOX AB enable swift diagnosis and subsequent isolation of patients, reducing cross contamination in clinical areas. Delivering results in minutes, both tests qualitatively detect C. difficile Toxins A and B directly from human faecal specimens.

Clinical symptoms of C. difficile associated disease (CDAD) were once thought to be solely due to Toxin A. However, there is growing evidence that Toxin B may also play an important role in the pathogenesis of C. difficile. According to Inverness Medical’s VP International Business, David Walton, it is becoming mandatory in an increasing number of countries to use a test that detects both toxins.

A positive or negative result can be achieved in approximately 10 minutes.

Latest Issues

AESCULAP ACADEMY LIVE - Circular Economy in Action

B. Braun Business Centre, Sheffield
Friday 10th July 2026

AfPP Regional Conferences: Bristol

BAWA Leisure
18th July 2026

AfPP Annual National Conference 2026

Wyboston Lakes Resort
7th – 8th August 2026

The Annual Operating Theatres Show

Manchester (Etihad)
10th September 2026

AfPP Regional Conferences: London

Cavendish Conference Centre
12th September 2026

CSC Autumn Study Day 2026

Holiday Inn, Birmingham Airport - NEC by IHG
12th October 2026